“Maximum change scenario”: The biotech company’s Brexit business diary
In the second of our inside stories from British businesses, the regional manager of a biotechnology firm tells us how his company is preparing for every…
ByNew Times,
New Thinking.
In the second of our inside stories from British businesses, the regional manager of a biotechnology firm tells us how his company is preparing for every…
By Peter HallIn June 2010, the tech giant Tesla held its Initial Public Offering, raising $226.1m for the company. With his family and…
By Peter HallThe risks and rewards of the tech mogul's $70bn bid to turn his company into a “reverse unicorn”.
By Peter HallThere are few boasts that Conservative politicians enjoy making more than “income inequality has fallen”. It suggests that austerity,…
By George Eaton and Peter Hall